Vivos Fungsi Utama: Sistem Bedah Ophthalmik dening Olcayto Guelec and David Geuder

Karya Vivos Fungsi Utama: Sistem Bedah Ophthalmik dening Olcayto Guelec and David Geuder minangka pemenang sing diajeni banget saka A' Design Award Emas 2026 sing bergengsi ing Kategori Kompetisi Desain Piranti Usada lan Peralatan Medis.

EmasProduk Usada· 2026

Vivos Fungsi Utama: Sistem Bedah Ophthalmik

dening Olcayto Guelec and David Geuder

Klien: Geuder AG

Pemenang A' Design Award Emas ing Kategori Produk Usada

56,783

Pemenang Penghargaan Terverifikasi

Verifikasi Status Penghargaan kanggo #182492

Deleng ing A' Design Award Siaran Pers Lencana Penghargaan

Warna

Desaine

Babagan Vivos Fungsi Utama: Sistem Bedah Ophthalmik

Teks Buku: Vivos ndhefinisi maneh workstation bedah minangka platform sing ngrembaka bareng karo ambisi klinis. Telung konfigurasi, yaiku Core, Nova, lan Nova+, nambahi kemampuan tanpa ngganti sistem, iku siji-sijine arsitektur upgrade jinis iki ing bedah ophthalmik. Antarmuka tunggal, kang divalidasi ing 91,7 persen kepuasan panggunaan kaping pisanan tanpa latihan sadurunge, nggambarake desain kang dibangun ngubengi dhokter bedah lan ora mung prosedure. Sambungan instrumen kang sumunar, bahan kang alus, lan detail kang prasaja menehi piranti iki kehadiran kang tentrem lan kebak kapitayan, bebas saka gangguan visual kang lumrah ing kategori iki.

Pangakuan

Babagan A' Design Award Emas

Vivos Fungsi Utama: Sistem Bedah Ophthalmik menang A' Design Award Emas, pangenalan sing prestisius banget sing diparingake marang desain kelas siji, nggumunake lan unggul. Pemenang Emas iku ciptaan sing inovatif banget, visioner lan sumunar nggumunake sing nggambarake kejeniusan, kawicaksanan lan kaprigelan para desainer. Vivos Fungsi Utama: Sistem Bedah Ophthalmik dikarepake dadi panemuan sing dipuji banget, pelopor tren lan monumental sing nyedhiyakake nilai sing durung tau ana. Desain sing menang A' Design Award Emas iki iku proyek sing nggumunake lan dihormati sing paring manfaat gedhe lan nyurung maju wates seni, sains, desain lan teknologi. Vivos Fungsi Utama: Sistem Bedah Ophthalmik nuwuhake perasaan kekarepan sing kuwat, nggugah semangat, nyengkuyung kreativitas lan narik kawigaten kita.

Ing Mburi Desain

Kit Pers

Kredit, anggota tim lan detail teknis sing diwenehake dening desainer.

Sifat Unik: Vivos is the only ophthalmic surgery system that grows with clinical needs. Core for cataract. Nova adds vitrectomy. Plus adds laser. One platform. One interface. One training investment. Independent usability validation confirmed 92 percent user satisfaction among first time users. Illuminated connection sockets were rated positively by all study participants. Premium materials and restrained detailing give the device a likeable presence without the visual noise typical of the category.
Ukuran & Kemasan: Display: 24 inch capacitive touchscreen. Vitrectomy: up to 40000 cuts per min. Vacuum: up to 700 mmHg, highest in category. Phacoemulsification: 53 kHz piezoelectric. IOP: active real-time (VIVOS Balance). Endolaser: 532 nm. Illumination: SOLEA LED, 16.9M colours, 2 ports, Retina Protection Mode. CE pending, submitted Feb 2026. ISO 13485 2016.
Tag: Ophthalmic Surgery System, Medical Device Design, Phacoemulsification, Vitrectomy, Modular Medical Platform, Surgical Ergonomics, Workflow Design, German Medical Engineering, Usability Validation, Premium Medical Aesthetics
Teknologi Produksi: Medical-grade polycarbonate housing, antimicrobial surface coating rated for over 10,000 disinfection cycles. Piezoelectric phacoemulsification at 53 kHz with beveled-up probe geometry for optimised fluidics. Pneumatic vitrectomy probe up to 40,000 cuts/min. IEC 60601-1 compliant. Modular quick-change cassette - single or multi-patient - tool-free exchange. Compatible with older phaco handpieces, protecting prior investment. Individually assembled in Heidelberg. ISO 13485:2016, IEC 62366-1, IEC 60601-1, CE pending
Tantangan Desain: The central challenge was integrating six surgical functions, historically distributed across two to three separate devices, into a single platform without increasing cognitive load. Internally, decades of segmented product architecture and a 75-year heritage required rethinking established engineering logic. Externally, MDR regulations, IEC 62366 1 usability standards and strict OR hygiene constraints limited design freedom. Maintaining identical UX across Core, Nova and Plus while ensuring durability for thousands of cleaning cycles demanded systemic redesign rather than incremental improvement.
Riset: Usability research was conducted. Objective: reduce cognitive load without limiting clinical capability. Methodology: iterative co-design workshops with surgeons, Geuder teams and engineering, followed by independent summative validation per IEC 62366-1. Data collection included usability testing and task-based evaluations. Participants: 13 first-time users at RWTH Aachen University, 2026. Results: 91.7% satisfaction, no unacceptable residual risks. Insights validated the workflow UI, surgeon profiles and illuminated sockets, contributing to greater efficiency, improved patient safety and long-term system adoption in clinical practice.
Inspirasi: Ophthalmic surgery is precise. Why should its devices remain fragmented, complex and visually uninspiring. Anterior and posterior procedures require separate investments, training and ecosystems not because clinical need requires it but because no manufacturer redesigned the architecture around the surgeon. Geuder AG with seventy five years of ophthalmic expertise asked what if one platform could grow without hardware replacement. Validated by independent study and unique in its modular upgrade logic.
Durasi Proyek: The project was developed in Heidelberg, Germany by Geuder AG. Development spanned multiple months with iterative design and engineering phases conducted in close collaboration with ophthalmic surgeons and operating room nursing staff. Summative usability validation was performed at RWTH Aachen University in early 2026. CE Mark application was submitted on 27 February 2026. Public market launch is scheduled for June 2026.
Alur Operasi: Before each procedure, the surgeon selects a personal profile, preloading preferred settings and pedal sensitivity. A three-column touchscreen maps each surgical step as a visual sequence. Colour-coded modules allow instant identification in a darkened theatre. Illuminated sockets guide instrument connection by touch. The foot pedal, with individually adjustable actuation force, controls fluid flow and laser hands-free. Eye pressure is monitored and adjusted in real time.
Anggota Tim: Collaboration between Geuder AG's Engineering, Quality Management, Regulatory Affairs, Product Management, Service, Application, Development, and Sales departments.
Kredit Gambar: Photography Geuder AG, 2026